AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal (NASDAQ:AZN)
In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to accumulate U.S. vaccine ...
In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to accumulate U.S. vaccine ...
© Reuters. EDMONTON - Capital Energy Corp. (TSX:CPX), a longtime Canadian power firm, has considerably expanded its operational capability with ...
Copyright © 2023 Financials Up.
Financials Up is not responsible for the content of external sites.
Copyright © 2023 Financials Up.
Financials Up is not responsible for the content of external sites.